

"Advanced haemodynamic monitoring proven to reduce surgical complications globally"
Deltex Medical develops haemodynamic monitoring systems enabling clinicians to make precise, evidence based decisions in surgery and critical care. Its flagship oesophageal Doppler monitoring measures real time blood flow from the aorta, helping teams maintain optimal fluid balance and prevent complications like acute kidney injury, respiratory distress, and surgical infections. Recognised by NICE as a high impact innovation, Deltex operates in over 30 countries. The newest platform, TrueVue, combines clinical precision with portable hardware and intuitive controls. By translating rigorous evidence into practical tools, Deltex empowers anaesthetists and critical care specialists to deliver safer outcomes while reducing care costs.


78
Team Members
1982
Founded
Medical Devices
Sector
Hybrid
Work Environment
A healthcare system where haemodynamic monitoring is a universal standard, enabling every patient facing major surgery or critical care to benefit from precision guided fluid management and measurably safer clinical outcomes.
Deltex Medical exists to make oesophageal Doppler monitoring the standard of care wherever possible, benefiting patients and healthcare providers through evidence based technology that reduces complications and improves outcomes.